► Home ﹥News > 2014

  • HBV Rebounds After Stopping Entecavir, Switching to Interferon May Help… read more
  • PharmaEssentia upbeat on trials in Europe for bone marrow disease drug… read more
  • MAR
    PharmaEssentia is listed on emerging stock market… read more
    APR Europe a promising market for new drug… read more
    The PROUD-PV Study… read more

    Copyright © 2008 PharmaEssentia Corporation All Rights Reserved.